Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity‐modulated radiotherapy and 3‐dimensional conformal radiotherapy
Makoto Ito(Fujita Health University), Yasuhisa Hasegawa(Asahi University), Daiki Kato(Aichi Cancer Center), Natsuo Tomita(Aichi Cancer Center), Masahiro Tajika(Aichi Cancer Center), Takeshi Kodaira(Aichi Cancer Center), Yutaro Koide(Aichi Cancer Center), Kei Muro(Aichi Cancer Center), Hiroyuki Tachibana(Aichi Cancer Center), Tetsuya Abe(Aichi Cancer Center), Yasumasa Niwa(Aichi Cancer Center), Chiyoko Makita(Aichi Cancer Center)
Cited by 32
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2018|1.3k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k